Healthcare provider profile · identity verified

Michael J Perry, M.D.

Family Practice · VIRGINIA BEACH, VA · NPI 1568441202

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	500	185
Rosuvastatin Calcium	Rosuvastatin Calcium	392	152
Albuterol Sulfate Hfa	Albuterol Sulfate	359	135
Amlodipine Besylate	Amlodipine Besylate	301	117
Lisinopril	Lisinopril	262	93
Losartan Potassium	Losartan Potassium	260	92
Metformin Hcl	Metformin Hcl	242	91
Diclofenac Sodium	Diclofenac Sodium	241	122
Fluticasone Propionate	Fluticasone Propionate	229	91
Omeprazole	Omeprazole	209	82
Levothyroxine Sodium	Levothyroxine Sodium	200	72
Glipizide	Glipizide	167	61
Furosemide	Furosemide	166	77
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	162	50
Trazodone Hcl	Trazodone Hcl	141	52
Tamsulosin Hcl	Tamsulosin Hcl	138	58
Alendronate Sodium	Alendronate Sodium	136	50
Hydrochlorothiazide	Hydrochlorothiazide	132	47
Gabapentin	Gabapentin	129	55
Carvedilol	Carvedilol	110	47
Pantoprazole Sodium	Pantoprazole Sodium	110	55
Clopidogrel	Clopidogrel Bisulfate	109	43
Metoprolol Tartrate	Metoprolol Tartrate	105	42
Montelukast Sodium	Montelukast Sodium	100	43
Hydralazine Hcl	Hydralazine Hcl	91	35
Prednisone	Prednisone	91	45
Azithromycin	Azithromycin	90	49
Potassium Chloride	Potassium Chloride	90	35
Ciprofloxacin Hcl	Ciprofloxacin Hcl	89	75
Allopurinol	Allopurinol	88	34
Sertraline Hcl	Sertraline Hcl	87	32
Duloxetine Hcl	Duloxetine Hcl	83	32
Warfarin Sodium	Warfarin Sodium	82	24
Metoprolol Succinate	Metoprolol Succinate	79	42
Eliquis	Apixaban	78	22
Metformin Hcl Er	Metformin Hcl	74	28
Triamcinolone Acetonide	Triamcinolone Acetonide	66	42
Tramadol Hcl	Tramadol Hcl	64	15
Naproxen	Naproxen	63	31
Tizanidine Hcl	Tizanidine Hcl	62	29
Simvastatin	Simvastatin	59	21
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	54	21
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	53	16
Buspirone Hcl	Buspirone Hcl	51	24
Atenolol	Atenolol	48	13
Nitroglycerin	Nitroglycerin	48	33
Isosorbide Mononitrate Er	Isosorbide Mononitrate	45	18
Bumetanide	Bumetanide	42	17
Spironolactone	Spironolactone	42	19
Famotidine	Famotidine	40	20
Ozempic	Semaglutide	38	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	37	suppressed
Finasteride	Finasteride	36	14
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	36	suppressed
Bupropion Xl	Bupropion Hcl	35	suppressed
Pravastatin Sodium	Pravastatin Sodium	34	13
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	33	13
Mirtazapine	Mirtazapine	33	15
Oxybutynin Chloride Er	Oxybutynin Chloride	33	17
Meclizine Hcl	Meclizine Hcl	31	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	29	suppressed
Cephalexin	Cephalexin	28	20
Ezetimibe	Ezetimibe	28	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	28	15
Ibuprofen	Ibuprofen	28	15
Amoxicillin	Amoxicillin	27	16
Glipizide Er	Glipizide	27	suppressed
Januvia	Sitagliptin Phosphate	27	suppressed
Lorazepam	Lorazepam	26	suppressed
Ondansetron Odt	Ondansetron	25	14
Pioglitazone Hcl	Pioglitazone Hcl	25	12
Ropinirole Hcl	Ropinirole Hcl	24	suppressed
Bupropion Hcl Sr	Bupropion Hcl	23	11
Donepezil Hcl	Donepezil Hcl	23	11
Alprazolam	Alprazolam	22	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	21	suppressed
Symbicort	Budesonide/Formoterol Fumarate	21	suppressed
Citalopram Hbr	Citalopram Hydrobromide	20	suppressed
Meloxicam	Meloxicam	20	13
Methylprednisolone	Methylprednisolone	20	18
Chlorthalidone	Chlorthalidone	19	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	19	suppressed
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	19	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	19	suppressed
Baclofen	Baclofen	18	suppressed
Clonazepam	Clonazepam	18	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	18	suppressed
Metronidazole	Metronidazole	18	12
Morphine Sulfate Er	Morphine Sulfate	18	suppressed
Xarelto	Rivaroxaban	18	suppressed
Fluconazole	Fluconazole	17	15
Jardiance	Empagliflozin	17	suppressed
Lactulose	Lactulose	17	suppressed
Levofloxacin	Levofloxacin	17	12
Ibu	Ibuprofen	16	suppressed
Levetiracetam	Levetiracetam	16	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	16	suppressed
Nifedipine Er	Nifedipine	15	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	15	14
Lidocaine	Lidocaine	14	suppressed
Novolog Mix 70-30	Insulin Aspart Prot/Insuln Asp	14	suppressed
Oxycodone Hcl	Oxycodone Hcl	14	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	14	suppressed
Breo Ellipta	Fluticasone/Vilanterol	13	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	13	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	13	suppressed
Methotrexate	Methotrexate Sodium	13	suppressed
Acyclovir	Acyclovir	12	suppressed
Amiodarone Hcl	Amiodarone Hcl	12	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	12	12
Fenofibrate	Fenofibrate	12	suppressed
Midodrine Hcl	Midodrine Hcl	12	suppressed
Novolog Flexpen	Insulin Aspart	12	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	12	12
Sumatriptan Succinate	Sumatriptan Succinate	12	suppressed
Trulicity	Dulaglutide	12	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	11	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	11	suppressed
Colchicine	Colchicine	11	suppressed
Diazepam	Diazepam	11	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	11	suppressed
Synthroid	Levothyroxine Sodium	11	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	11	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error